Correlation Between ZyVersa Therapeutics and ABVC Biopharma
Can any of the company-specific risk be diversified away by investing in both ZyVersa Therapeutics and ABVC Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ZyVersa Therapeutics and ABVC Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ZyVersa Therapeutics and ABVC Biopharma, you can compare the effects of market volatilities on ZyVersa Therapeutics and ABVC Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ZyVersa Therapeutics with a short position of ABVC Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of ZyVersa Therapeutics and ABVC Biopharma.
Diversification Opportunities for ZyVersa Therapeutics and ABVC Biopharma
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between ZyVersa and ABVC is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding ZyVersa Therapeutics and ABVC Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ABVC Biopharma and ZyVersa Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ZyVersa Therapeutics are associated (or correlated) with ABVC Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ABVC Biopharma has no effect on the direction of ZyVersa Therapeutics i.e., ZyVersa Therapeutics and ABVC Biopharma go up and down completely randomly.
Pair Corralation between ZyVersa Therapeutics and ABVC Biopharma
Given the investment horizon of 90 days ZyVersa Therapeutics is expected to generate 1.64 times more return on investment than ABVC Biopharma. However, ZyVersa Therapeutics is 1.64 times more volatile than ABVC Biopharma. It trades about 0.15 of its potential returns per unit of risk. ABVC Biopharma is currently generating about -0.05 per unit of risk. If you would invest 123.00 in ZyVersa Therapeutics on October 26, 2024 and sell it today you would earn a total of 25.08 from holding ZyVersa Therapeutics or generate 20.39% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
ZyVersa Therapeutics vs. ABVC Biopharma
Performance |
| Timeline |
| ZyVersa Therapeutics |
| ABVC Biopharma |
ZyVersa Therapeutics and ABVC Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ZyVersa Therapeutics and ABVC Biopharma
The main advantage of trading using opposite ZyVersa Therapeutics and ABVC Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ZyVersa Therapeutics position performs unexpectedly, ABVC Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ABVC Biopharma will offset losses from the drop in ABVC Biopharma's long position.| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
| ABVC Biopharma vs. Indaptus Therapeutics | ABVC Biopharma vs. Pasithea Therapeutics Corp | ABVC Biopharma vs. Forte Biosciences | ABVC Biopharma vs. Akari Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |